| Year |
Citation |
Score |
| 2013 |
Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Oliveira C, Justicia A, Griffith JK, Heaphy CM, Bernardo M, Kirkpatrick B. Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain, Behavior, and Immunity. 28: 49-53. PMID 23207109 DOI: 10.1016/J.Bbi.2012.11.009 |
0.498 |
|
| 2012 |
Butler KS, Hines WC, Heaphy CM, Griffith JK. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Cancer Medicine. 1: 165-75. PMID 23342266 DOI: 10.1002/Cam4.14 |
0.773 |
|
| 2012 |
Trujillo KA, Jones AC, Griffith JK, Bisoffi M. Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer. 2012: 302894. PMID 22666601 DOI: 10.1155/2012/302894 |
0.349 |
|
| 2012 |
Jones AC, Trujillo KA, Phillips GK, Fleet TM, Murton JK, Severns V, Shah SK, Davis MS, Smith AY, Griffith JK, Fischer EG, Bisoffi M. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. The Prostate. 72: 1159-70. PMID 22127986 DOI: 10.1002/Pros.22465 |
0.403 |
|
| 2011 |
Trujillo KA, Hines WC, Vargas KM, Jones AC, Joste NE, Bisoffi M, Griffith JK. Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue. Molecular Cancer Research : McR. 9: 1209-21. PMID 21775421 DOI: 10.1158/1541-7786.Mcr-10-0424 |
0.771 |
|
| 2011 |
Trujillo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, Vo P, Butler KS, Joste NE, Bisoffi M, Griffith JK. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. International Journal of Cancer. Journal International Du Cancer. 129: 1310-21. PMID 21105047 DOI: 10.1002/Ijc.25788 |
0.797 |
|
| 2010 |
Heaphy CM, Fleet TM, Treat EG, Lee SJ, Smith AY, Davis MS, Griffith JK, Fischer EG, Bisoffi M. Organ-wide telomeric status in diseased and disease-free prostatic tissues. The Prostate. 70: 1471-9. PMID 20687220 DOI: 10.1002/Pros.21182 |
0.606 |
|
| 2010 |
Treat EG, Heaphy CM, Massie LW, Bisoffi M, Smith AY, Davis MS, Griffith JK. Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer. Urology. 75: 724-9. PMID 19615720 DOI: 10.1016/J.Urology.2009.04.032 |
0.607 |
|
| 2009 |
Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Research and Treatment. 118: 229-39. PMID 19685287 DOI: 10.1007/S10549-009-0504-0 |
0.674 |
|
| 2009 |
Haaland CM, Heaphy CM, Butler KS, Fischer EG, Griffith JK, Bisoffi M. Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization. International Journal of Oncology. 35: 537-46. PMID 19639174 DOI: 10.3892/Ijo_00000365 |
0.787 |
|
| 2009 |
Fernandez-Egea E, Bernardo M, Heaphy CM, Griffith JK, Parellada E, Esmatjes E, Conget I, Nguyen L, George V, Stöppler H, Kirkpatrick B. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophrenia Bulletin. 35: 437-42. PMID 19279086 DOI: 10.1093/Schbul/Sbn169 |
0.486 |
|
| 2009 |
Heaphy CM, Bisoffi M, Joste NE, Baumgartner KB, Baumgartner RN, Griffith JK. Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Research and Treatment. 117: 17-24. PMID 18785004 DOI: 10.1007/S10549-008-0165-4 |
0.656 |
|
| 2008 |
Heaphy CM, Treat EG, Fleet TM, Bisoffi M, Smith AY, Davis MS, Fischer EG, Griffith JK. FIELD EFFECT REVEALED BY 3D-MAPPING OF TELOMERE DNA CONTENT AND ALLELIC IMBALANCE IN WHOLE MOUNT PROSTATES Journal of Urology. 179: 725-725. DOI: 10.1016/S0022-5347(08)62114-X |
0.595 |
|
| 2007 |
Heaphy CM, Bisoffi M, Griffith JK. Diagnostic significance of allelic imbalance in cancer. Expert Opinion On Medical Diagnostics. 1: 159-68. PMID 23489303 DOI: 10.1517/17530059.1.2.159 |
0.674 |
|
| 2007 |
Heaphy CM, Baumgartner KB, Bisoffi M, Baumgartner RN, Griffith JK. Telomere DNA content predicts breast cancer-free survival interval. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7037-43. PMID 18056180 DOI: 10.1158/1078-0432.Ccr-07-0432 |
0.689 |
|
| 2007 |
Heaphy CM, Hines WC, Butler KS, Haaland CM, Heywood G, Fischer EG, Bisoffi M, Griffith JK. Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. The Journal of Molecular Diagnostics : Jmd. 9: 266-71. PMID 17384220 DOI: 10.2353/Jmoldx.2007.060115 |
0.733 |
|
| 2007 |
Liu Z, Wan G, Heaphy C, Bisoffi M, Griffith JK, Hu CA. A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model. Molecular and Cellular Biochemistry. 297: 179-87. PMID 17119852 DOI: 10.1007/S11010-006-9345-X |
0.594 |
|
| 2007 |
Treat EG, Heaphy CM, Bisoffi M, Griffith JK, Smith AY, Davis MS. 1432: Telomere DNA Content Predicts Biochemical Recurrence in a Retrospective Analysis of Prostate Cancer Biopsies Journal of Urology. 177: 472-473. DOI: 10.1016/S0022-5347(18)31633-1 |
0.641 |
|
| 2006 |
Bisoffi M, Heaphy CM, Griffith JK. Telomeres: prognostic markers for solid tumors. International Journal of Cancer. 119: 2255-60. PMID 16858685 DOI: 10.1002/Ijc.22120 |
0.674 |
|
| 2006 |
Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Research and Treatment. 99: 193-202. PMID 16752076 DOI: 10.1007/S10549-006-9204-1 |
0.803 |
|
| 2006 |
Candia BJ, Hines WC, Heaphy CM, Griffith JK, Orlando RA. Protease nexin-1 expression is altered in human breast cancer. Cancer Cell International. 6: 16. PMID 16737540 DOI: 10.1186/1475-2867-6-16 |
0.78 |
|
| 2006 |
Heaphy CM, Bisoffi M, Fordyce CA, Haaland CM, Hines WC, Joste NE, Griffith JK. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. International Journal of Cancer. 119: 108-16. PMID 16450377 DOI: 10.1002/Ijc.21815 |
0.758 |
|
| 2005 |
Hines WC, Fajardo AM, Joste NE, Bisoffi M, Griffith JK. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Molecular Cancer Research : McR. 3: 503-9. PMID 16179497 DOI: 10.1158/1541-7786.Mcr-05-0031 |
0.758 |
|
| 2005 |
Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK. Association between cancer-free survival and telomere DNA content in prostate tumors. The Journal of Urology. 173: 610-4. PMID 15643274 DOI: 10.1097/01.Ju.0000143195.49685.Ce |
0.808 |
|
| 2004 |
Bisoffi M, Klima I, Gresko E, Durfee PN, Hines WC, Griffith JK, Studer UE, Thalmann GN. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955. The Journal of Urology. 172: 1145-50. PMID 15311059 DOI: 10.1097/01.Ju.0000135117.40086.Fa |
0.708 |
|
| 2002 |
Fordyce CA, Heaphy CM, Griffith JK. Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques. 33: 144-6, 148. PMID 12139239 DOI: 10.2144/02331Md02 |
0.801 |
|
| 1999 |
Griffith JK, Bryant JE, Fordyce CA, Gilliland FD, Joste NE, Moyzis RK. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Research and Treatment. 54: 59-64. PMID 10369081 DOI: 10.1023/A:1006128228761 |
0.783 |
|
| 1999 |
DONALDSON L, FORDYCE C, GILLILAND F, SMITH A, FEDDERSEN R, JOSTE N, MOYZIS R, GRIFFITH J. ASSOCIATION BETWEEN OUTCOME AND TELOMERE DNA CONTENT IN PROSTATE CANCER Journal of Urology. 162: 1788-1792. DOI: 10.1016/S0022-5347(05)68239-0 |
0.784 |
|
| 1994 |
Griffith JK, Cuellar DH, Fordyce CA, Hutchings KG, Mondragon AA. Structure and function of the class C tetracycline/H+ antiporter: three independent groups of phenotypes are conferred by TetA (C). Molecular Membrane Biology. 11: 271-7. PMID 7711837 DOI: 10.3109/09687689409160437 |
0.697 |
|
| Show low-probability matches. |